MGRX 10-Q: SEC filing
Mangoceuticals, Inc.
Filed with the SEC on · accession 0001493152-26-052611
MGRX filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +3.4% by the first close after the filing.
Summary of the filing
Mangoceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results including balance sheet, income statement, and stockholders' equity data.
Key details
How MGRX stock reacted
Close before
$0.15
Nov 13, 2026
First close after
+3.42%
$0.16
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MGRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MGRX?
Click hereFrequently asked questions
What did MGRX file with the SEC on Nov 16, 2026?
MGRX filed a 10-Q (SEC filing). Mangoceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results including balance sheet, income statement, and stockholders' equity data.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did MGRX stock react to this filing?
MGRX closed at $0.15 before the filing and $0.16 on Nov 16, 2026 (+3.42%).
Other MGRX SEC filings
- 8-K · SEC filingNov 13, 2026
- 8-K · SEC filingNov 6, 2026
- 8-K · Secondary offeringOct 9, 2026
- 424B5 · Secondary offeringOct 9, 2026
- SCHEDULE 13D/A · SEC filingOct 6, 2026
- 8-K · Material agreementOct 1, 2026
- 8-K · Contract lossAug 21, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Delisting noticeAug 4, 2026
- 8-K · Ceo changeJul 30, 2026
Get alerts when MGRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days